Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: An autoradiographic study

Brain Research

Volumn 795, Issue 1-2, 1998, Pages 55-62

  Elsworth, J D ^a   Brittan, M S ^a   Taylor, J R ^a   Sladek Jr , J R ^b   Redmond Jr , D E ^a   Innis, R B ^a,c   Zea Ponce, Y ^a,c   Roth, R H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Chicago Medical College   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

D2 receptor; Dopamine; Monkey; MPTP; Neural transplantation; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; MESENCEPHALON; MONKEY; NERVE GRAFT; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

EID: 0032496751     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00252-2     Document Type: Article

References (66)

1. E.D. Abercrombie, A.E. Bonatz, M.J. Zigmond, Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats, Brain Res. 525 (1990) 36-44.
2. A.K. Agrawal, R. Husain, R. Raghubir, A. Kumar, P.K. Seth, Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats, Int. J. Dev. Neurosci. 13 (1995) 105-111.
3. G.M. Alexander, D.L. Brainard, S.W. Gordon, M. Hichens, J.R. Grothusen, R.J. Schwartzman, Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates, Brain Res. 547 (1991) 181-189.
4. G.M. Alexander, R.J. Schwartzman, L. Brainard, S.W. Gordon, J.R. Grothusen, Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys, Brain Res. 588 (1992) 261-269.
5. G.M. Alexander, R.J. Schwartzman, J.R. Grothusen, L. Brainard, S.W. Gordon, Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment, Brain Res. 625 (1993) 276-282.
6. L.E. Annett, F.L. Martel, D.C. Rogers, R.M. Ridley, H.F. Baker, S.B. Dunnett, Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway, Exp. Neurol. 125 (1994) 228-246.
7. K. Bankiewicz, R.J. Mandel, M.V. Sofroniew, Trophism, transplantation, and animal models of Parkinson's disease, Exp. Neurol. 124 (1993) 140-149.
8. 3H]spiperone binding, Brain Res. 379 (1986) 294-299.
9. 3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy, Eur. J. Pharmacol. 99 (1984) 167-175.
10. A. Buck, G. Westera, M. Sutter, C. Albani, H.F. Kung, G.K. von Schulthess, Iodine-123-IBF SPECT evaluation of extrapyramidal diseases, J. Nucl. Med. 36 (1995) 1196-1200.
11. E. Castaneda, I.Q. Whishaw, T.E. Robinson, Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size, J. Neurosci. 10 (1990) 1847-1854.
12. A.R. Crossman, C.E. Clarke, S. Boyce, R.G. Robertson, M.A. Sambrook, MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms, Can. J. Neural. Sci. 14 (1987) 428-435.
13. T.M. Dawson, V.L. Dawson, F.H. Gage, L.J. Fisher, M.A. Hunt, J.K. Wamsley, Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra, Exp. Neurol. 111 (1991) 282-292.
14. J.D. Elsworth, M.S. Al-Tikriti, J.R. Sladek Jr., J.R. Taylor, R.B. Innis, D.E. Redmond Jr., R.H. Roth, Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function, Exp. Neurol. 126 (1994) 300-304.
15. J.D. Elsworth, M.S. Brittan, J.R. Taylor, J.R. Sladek Jr., M.S. Al-Tikriti, Y. Zea-Ponce, R.B. Innis, D.E. Redmond Jr., R.H. Roth, Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted MPTP-treated parkinsonian monkeys, Cell Transplant. 5 (1996) 315-325.
16. J.D. Elsworth, A.Y. Deutch, D.E. Redmond Jr., J.R. Sladek Jr., R.H. Roth, Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum, Life Sci. 40 (1987) 193-202.
17. J.D. Elsworth, A.Y. Deutch, D.E. Redmond Jr., J.R. Taylor, J.R. Sladek Jr., R.H. Roth, Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions, Neuroscience 33 (1989) 323-331.
18. J.D. Elsworth, R.H. Roth, Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease, Exp. Neurol. 144 (1997) 4-9.
19. J.D. Elsworth, R.H. Roth, Dopamine autoreceptor pharmacology and function: recent insights, in: K.A. Neve, R.L. Neve (Eds.), The Dopamine Receptors, Humana Press, Totowa, NJ, 1996, pp. 223-265.
20. J.D. Elsworth, J.R. Sladek Jr., J.R. Taylor, T.J. Collier, D.E. Redmond Jr., R.H. Roth, Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys, Neuroscience 72 (1996) 477-484.
21. P. Falardeau, P.J. Bedard, T. Di Paolo, Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys, Neurosci. Lett. 86 (1988) 225-229.
22. P. Falardeau, S. Bouchard, P.J. Bedard, R. Boucher, T. Di Paolo, Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys, Eur. J. Pharmacol. 150 (1988) 59-66.
23. W.J. Freed, G.N. Ko, D.L. Niehoff, M.J. Kuhar, B.J. Hoffer, L. Olson, H.E. Cannon-Spoor, J.M. Morihisa, R.J. Wyatt, Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra, Science 222 (1983) 937-939.
24. C. Gagnon, P.J. Bedard, L. Rioux, D. Gaudin, M.G. Martinoli, G. Pelletier, T. Di Paolo, Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat, Brain Res. 558 (1991) 251-263.
25. P. Gaspar, B. Bloch, C. Le Moine, D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons, Eur. J. Neurosci. 7 (1995) 1050-1063.
26. K.K. Gnanalingham, L.A. Smith, A.J. Hunter, P. Jenner, C.D. Marsden, Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study, Synapse 14 (1993) 184-194.
27. W.C. Graham, C.E. Clarke, S. Boyce, M.A. Sambrook, A.R. Crossman, G.N. Woodruff, Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity: II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis), Brain Res. 514 (1990) 103-110.
28. W.C. Graham, M.A. Sambrook, A.R. Crossman, Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism, Brain Res. 602 (1993) 290-303.
29. M.T. Herrero, S.J. Augood, H. Asensi, E.C. Hirsch, Y. Agid, J.A. Obeso, P.C. Emson, Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys, Brain Res. Mol. Brain Res. 42 (1996) 149-155.
30. S.M. Hersch, B.J. Ciliax, C.A. Gutekunst, H.D. Rees, C.J. Heilman, K.K. Yung, J.P. Bolam, E. Ince, H. Yi, A.I. Levey, Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents, J. Neurosci. 15 (1995) 5222-5237.
31. G.W. Huntley, J.H. Morrison, A. Prikhozhan, S.C. Sealfon, Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum, Brain Res. Mol. Brain Res. 15 (1992) 181-188.
32. J.N. Joyce, Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: III. Results in Parkinson's disease cases, Brain Res. 600 (1993) 156-160.
33. J.N. Joyce, J.F. Marshall, K.S. Bankiewicz, I.J. Kopin, D.M. Jacobowitz, Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density, Brain Res. 382 (1986) 360-364.
34. J.N. Joyce, A. Murray, Distribution of D1- and D2-like dopamine receptors in human brain, in: H.B. Niznik (Ed.), Dopamine Receptors and Transporters: Pharmacology, Structure, and Function, Marcel Dekker, New York, 1994, pp. 345-382.
35. Y. Kaseda, B. Ghetti, W.C. Low, J. Norton, H. Brittain, L.C. Triarhou, J.A. Richter, J.R. Simon, Age-related changes in striatal dopamine D2 receptor binding in weaver mice and effects of ventral mesencephalic grafts, Exp. Brain Res. 83 (1990) 1-8.
36. S.J. Kish, K. Shannak, O. Hornykiewicz, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications, New Engl. J. Med. 318 (1988) 876-880.
37. J.H. Kordower, C.G. Goetz, T.B. Freeman, C.W. Olanow, Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery, Exp. Neurol. 144 (1997) 41-46.
38. T.K. Koutouzis, D.F. Emerich, C.V. Borlongan, T.B. Freeman, D.W. Cahill, P.R. Sanberg, Cell transplantation for central nervous system disorders, Crit. Rev. Neurobiol. 8 (1994) 125-162.
39. M.P. Kung, H.F. Kung, J. Billings, Y. Yang, R.A. Murphy, A. Alavi, The characterization of IBF as a new selective dopamine D-2 receptor imaging agent, J. Nucl. Med. 31 (1990) 648-654.
40. T. Lee, P. Seeman, A. Rajput, I.J. Parley, O. Hornykiewicz, Receptor basis for dopaminergic supersensitivity in Parkinson's disease, Nature 273 (1978) 59-61.
41. O. Lindvall, Neural transplantation, Cell Transplant 4 (1995) 393-400.
42. M. Morissette, M. Goulet, F. Calon, P. Falardeau, P.J. Blanchet, P.J. Bedard, T. Di Paolo, Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine, Mol. Pharmacol. 50 (1996) 1073-1079.
43. K.A. Neve, R.L. Neve, S. Fidel, A. Janowsky, G.A. Higgins, Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2802-2806.
44. C.W. Olanow, J.H. Kordower, T.B. Freeman, Fetal nigral transplantation as a therapy for Parkinson's disease, Trends Neurosci. 19 (1996) 102-109.
45. I. Perez-Otano, C. Oset, M.R. Luquin, M.T. Herrero, J.A. Obeso, J. Del Rio, MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration, Neurosci. Lett. 175 (1994) 121-125.
46. C. Pifl, G. Schingnitz, O. Hornykiewicz, Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey, Neuroscience 44 (1991) 591-605.
47. Z.H. Qin, J.F. Chen, B. Weiss, Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors, J. Neurochem. 62 (1994) 411-420.
48. M.S. Rappaport, S.C. Sealfon, A. Prikhozhan, G.W. Huntley, J.H. Morrison, Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum, Brain Res. 616 (1993) 242-250.
49. D.E. Redmond Jr., R.H. Roth, D.D. Spencer, F. Naftolin, C. Leranth, R.J. Robbins, K.L. Marek, J.D. Elsworth, J.R. Taylor, K.J. Sass, J.R. Sladek Jr., Neural transplantation for neurodegenerative diseases: past, present, and future, Ann. New York Acad. Sci. 695 (1993) 258-266.
50. L. Rioux, D.P. Gaudin, G. C., P.J. Bedard, T. Di Paolo, Decrease of behavioral and biochemical supersensitivity of rat striatum by nigral grafts, Neuroscience 44 (1991) 75-83.
51. J.M. Rosenstein, Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation, Exp. Neurol. 133 (1995) 1-6.
52. M. Savasta, A. Dubois, J. Benavides, B. Scatton, Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission, Neurosci. Lett. 85 (1988) 119-124.
53. B. Scatton, M. Savasta, A. Dubois, C. Feuerstein, M. Manier, J. Benavides, Autoradiographic analysis of D1 and D2 dopamine receptor localization and plasticity in the rat and primate basal ganglia, in: N.A. Sharif, M.E. Lewis (Eds.), Brain Imaging: Techniques and Applications, Halsted, New York, 1989, pp. 95-109.
54. J.S. Schneider, Chronic exposure to low doses of MPTP: II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys, Brain Res. 534 (1990) 25-36.
55. P. Seeman, N.H. Bzowej, H.C. Guan, C. Bergeron, G.P. Reynolds, E.D. Bird, P. Riederer, K. Jellinger, W.W. Tourtellotte, Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases, Neuropsychopharmacology 1 (1987) 5-15.
56. S.R. Sesack, C. Aoki, V.M. Pickel, Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets, J. Neurosci. 14 (1994) 88-106.
57. D.J. Sirinathsinghji, S.B. Dunnett, A.J. Northrop, B.J. Morris, Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway: III. Reversal by embryonic nigral dopamine grafts, Neuroscience 37 (1990) 757-766.
58. J.R. Sladek Jr., J.D. Elsworth, R.H. Roth, L.E. Evans, T.J. Collier, S.J. Cooper, J.R. Taylor, D.E. Redmond Jr., Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates, Exp. Neurol. 122 (1993) 16-27.
59. J.R. Sladek Jr., J.D. Elsworth, J.R. Taylor, R.H. Roth, D.E. Redmond Jr., Techniques for neural transplantation in non-human primates, in: C. Ricordi, R.G. Landes (Eds.), Techniques for Neural Transplantation, CRC Press, Austin, 1995, pp. 391-408.
60. P. Sokoloff, B. Giros, M.P. Martres, M.L. Bouthenet, J.C. Schwartz, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature 347 (1990) 146-151.
61. J.R. Taylor, J.D. Elsworth, R.H. Roth, J.R. Sladek, D.E. Redmond, Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabeus), Neuroscience 81 (1997) 745-755.
62. J.R. Taylor, J.D. Elsworth, J.R. Sladek Jr., T.J. Collier, R.H. Roth, D.E. Redmond Jr., Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys, Cell Transplant. 4 (1995) 13-26.
63. R.D. Todd, J. Carl, S. Harmon, K.L. O'Malley, J.S. Perlmutter, Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) denervation in baboons, J. Neurosci. 16 (1996) 7776-7782.
64. L.C. Triarhou, C. Sola, G. Mengod, F.J. Garcia-Ladona, B. Landwehrmeyer, B. Ghetti, J.M. Palacios, Ventral mesencephalic grafts in the neostriatum of the weaver mutant mouse: structural molecule and receptor studies, Cell Transplant. 4 (1995) 39-48.
65. US Public Health Service Guide for Care and Use of Animals, Washington DC, Government Printing Office (1985).
66. D.M. Weiner, A.I. Levey, M.R. Brann, Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 7050-7054.